Laura Brege

Laura Brege is Managing Director of Cervantes Life Science Partners, LLC, a health care advisory and consulting company.  Earlier, Ms. Brege served as President and CEO of Nodality, Inc., a privately held biotechnology company focused in oncology and immunology.   Previously, Ms. Brege held the roles of chief operating officer, executive vice president, chief business officer and head of corporate affairs at Onyx Pharmaceuticals, Inc., a biopharmaceutical company that developed and marketed medicines for the treatment of cancer.  Prior to joining Onyx in 2006, Ms. Brege was a general partner at Red Rock Capital Management, a technology venture capital firm, and CFO at COR Therapeutics, Inc.  Earlier, Ms. Brege was CFO of Flextronics, Inc. and Treasurer of The Cooper Companies. Ms. Brege currently serves as a director of Acadia Pharmaceuticals Inc., Aratana Therapeutics, Inc., Dynavax Technologies Corporation, Pacira Pharmaceuticals, Inc. and Portola Pharmaceuticals, Inc.